about
The Ins and Outs of Anthrax ToxinRoles of Anthrax Toxin Receptor 2 in Anthrax Toxin Membrane Insertion and Pore FormationAnthrax lethal and edema toxins in anthrax pathogenesisBacillus anthracis edema factor substrate specificity: evidence for new modes of actionStudies in mice reveal a role for anthrax toxin receptors in matrix metalloproteinase function and extracellular matrix homeostasisCharacterization of Protein-Protein Interfaces through a Protein Contact Network ApproachTargeting Bacillus anthracis toxicity with a genetically selected inhibitor of the PA/CMG2 protein-protein interactionCMG2/ANTXR2 regulates extracellular collagen VI which accumulates in hyaline fibromatosis syndromeThe genetic basis of ankylosing spondylitis: new insights into disease pathogenesisExpression and purification of the functional ectodomain of human anthrax toxin receptor 2 in Escherichia coli Origami B cells with assistance of bacterial Trigger FactorUpregulation of the host SLC11A1 gene by Clostridium difficile toxin B facilitates glucosylation of Rho GTPases and enhances toxin lethality.Human genetic variation altering anthrax toxin sensitivity.Capillary morphogenesis protein-2 is required for mouse parturition by maintaining uterine collagen homeostasis.Selective blockade of tumor angiogenesis.Diagnosis implications of the whole genome sequencing in a large Lebanese family with hyaline fibromatosis syndrome.Anthrax Susceptibility: Human Genetic Polymorphisms Modulating ANTXR2 Expression.1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2.Wnt/β-catenin signaling plays a key role in the development of spondyloarthritis.Calpain-dependent cytoskeletal rearrangement exploited for anthrax toxin endocytosis.Ubiquitin-dependent folding of the Wnt signaling coreceptor LRP6Transcellular tunnel dynamics: Control of cellular dewetting by actomyosin contractility and I-BAR proteins.Anthrax toxin receptor 2a controls mitotic spindle positioning.Infantile systemic hyalinosis: Report of two severe cases from Saudi Arabia and review of the literature.Expression, Purification, and Biophysical Characterization of a Secreted Anthrax Decoy Fusion Protein in Nicotiana benthamiana.Biomimetic surface patterning for long-term transmembrane access.In-depth analysis of hyaline fibromatosis syndrome frameshift mutations at the same site reveal the necessity of personalized therapy.CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients.A pivotal role for a conserved bulky residue at the α1-helix of the αI integrin domain in ligand binding.ANTXR2 Knock-Out Does Not Result in the Development of Hypertension in Rats.Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/β-catenin pathway.MicroRNA-124 involves in ankylosing spondylitis by targeting ANTXR2.The genetic basis of hyaline fibromatosis syndrome in patients from a consanguineous background: a case series.TEM8 functions as a receptor for uPA and mediates uPA-stimulated EGFR phosphorylation
P2860
Q26765437-2EC24BB2-70BA-4B9A-8601-7656894B48CCQ26775093-47228445-93D3-4856-BFA5-1436EE91F665Q26852034-F9F4A036-A94D-4C4B-81C6-4FF6CE93B94AQ27000357-3F61BF54-01D9-4271-B315-8465FC004324Q27010122-B305CC78-8471-4AC8-8866-42CBE81E3133Q28392590-4A01475B-C0E1-4326-BC55-85D2285036AEQ33780004-DCDDD361-A25E-45F2-AE52-4944FF5DD9ABQ33804741-9E6BF139-84D6-4BC4-BB9F-7317E1E05A09Q33806334-A2C868C7-D93D-4D29-A2F4-7600B66839F5Q34462631-FD4C0991-9398-4D5F-BDC6-7F928B98B7A3Q34729613-703A0836-4756-43F0-82E3-7317A1DDE0B9Q35779094-FD8EEC21-F07C-43E7-9B74-959B4BA6AE43Q36037374-019C3A55-4178-4A01-B13A-5A9B79F45C7DQ36059674-A0AEA2EA-8155-4A82-BFD1-FEFFA7A09ADFQ36254263-7675D6FC-846B-44C6-8F77-8FE5F50350D5Q36507163-C2268C1B-213B-4859-9854-04B7FF8A263FQ36691673-3D610C03-D3E9-4253-96E0-9F6C215A29BAQ36717343-BA2E8DD9-FB56-4AED-BFB2-3D5AEDD38DACQ37240560-FD259C2B-D38A-4BA5-9E46-6F7167BF0589Q37404478-A067C52B-1506-4486-A0B2-4E8C6148A0B4Q38063267-1D228C00-B6D3-4353-A391-D5A00DBCEA48Q38319622-9BA13AE2-39D4-494E-822C-B96ADA099D57Q38838182-06490574-DAAE-4F5B-BE50-30506072C17AQ40395310-57836D88-5288-459B-A9A7-F917E39AD4B8Q40983154-7D71FD3A-F816-4557-B270-5BA6228C03FDQ45914563-18A969C5-A823-41D9-BF72-8530EFC55BB5Q47320197-C69D709E-C8E1-49F9-B072-6C79AB6BAF35Q47699535-28951550-BB15-4A96-8F7A-845BE6996BF6Q50957790-CBC0E4FA-6C5D-4AC1-8B0A-C06DF3A2A196Q52584565-8380474B-BBFC-4F7E-8EC2-753114A3D5E0Q53023578-FB82CBC4-041D-407C-AF71-267302FE7D7EQ55022257-38142226-C807-4DB4-9C71-D8EF532897CDQ58706528-9E391F06-8FBD-4979-A824-BC0ABFAE0E68
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The dark sides of capillary morphogenesis gene 2.
@ast
The dark sides of capillary morphogenesis gene 2.
@en
type
label
The dark sides of capillary morphogenesis gene 2.
@ast
The dark sides of capillary morphogenesis gene 2.
@en
prefLabel
The dark sides of capillary morphogenesis gene 2.
@ast
The dark sides of capillary morphogenesis gene 2.
@en
P2093
P2860
P356
P1433
P1476
The dark sides of capillary morphogenesis gene 2.
@en
P2093
Ekkehart Lausch
F Gisou van der Goot
Julie Deuquet
P2860
P356
10.1038/EMBOJ.2011.442
P407
P577
2011-12-06T00:00:00Z